Saurav Brahmachari

Saurav Brahmachari Email and Phone Number

Senior Scientist at Valted Seq Inc. (A subsidiary of D&D Pharmatech) @ ValtedSeq
Saurav Brahmachari's Location
Washington DC-Baltimore Area, United States, United States
Saurav Brahmachari's Contact Details

Saurav Brahmachari work email

About Saurav Brahmachari

• As a highly motivated neuroscientist with more than 18 years of experience in the field of neurodegenerative diseases, I investigate and lead translational neurodegeneration research from discovery and validation of molecular mediators of neurodegeneration to development of preclinical studies for disease modifying therapies, as well as biomarker identification and assay development for neurodegenerative diseases. • Leadership and management: Extensive experience in managing and supervising scientists, technicians, postdocs, graduate and undergraduate students, project management, project planning and prioritization, and strategy development.• Collaboration: Successfully conducted and led multiple primary and collaborative research projects as a team leader or a key contributor.• Communications: Extensive experience in scientific communications (prolific scientific writer of research papers, project reports, technical/white paper, grant proposals, review articles, book chapter etc.; journal editor/reviewer; grant reviewer; speaker and presenter at numerous national and international meetings/conferences).

Saurav Brahmachari's Current Company Details
ValtedSeq

Valtedseq

View
Senior Scientist at Valted Seq Inc. (A subsidiary of D&D Pharmatech)
Saurav Brahmachari Work Experience Details
  • Valtedseq
    Senior Scientist
    Valtedseq Aug 2021 - Present
    • Support and lead cross-functional team efforts with neuroscience/neurodegenerative disease-based strategic inputs to advance the understanding and interpretation of internally generated single-nuclei RNA-seq/bioinformatics-driven data from the standpoint of neurodegenerative diseases and identify novel targets with potential for therapeutic and/or biomarker development. • Lead biomarker assay development for neurodegenerative diseases: Develop planning and strategy, design experimental studies, and supervise and manage a team of a scientist and technicians for liquid biopsy-based biomarker assay development and clinical and analytical validation of the biomarkers for Parkinson’s disease using high-sensitivity ELISA platform.• Write reports and technical/white papers for internal and external communications, prepare and present research internally, externally as well as at international scientific meetings/conferences.• Provide overall support to our cross-functional teams as a scientific advisor.
  • The Johns Hopkins University School Of Medicine
    Research Associate, Faculty
    The Johns Hopkins University School Of Medicine Sep 2016 - Jul 2021
    Baltimore, Md, Us
    • Developed liquid biopsy-based biomarker assays for Parkinson’s disease using high-sensitivity ELISA platforms. • Contributed to a patent on Biomarkers for neurodegenerative diseases.• Developed and performed preclinical research to evaluate neuroprotective efficacy of antisense oligonucleotides in Parkinson’s disease.• Identified and validated a novel molecular target of alpha-synuclein neurodegeneration using genetic and idiopathic PD relevant rodent models of Parkinson’s disease and alpha synucleionopathies.• Generated and characterized novel genetic rodent models of Parkinson’s disease.• Directly mentored and supervised a group of undergraduate and graduate students, and a research technician.• Contributed significantly to many internal collaborations.• Led efforts in many external collaborations with both academia and industries.• Wrote and published papers as senior author and co-author, wrote grants and progress reports.
  • The Johns Hopkins University School Of Medicine
    Post Doctoral Fellow
    The Johns Hopkins University School Of Medicine Sep 2010 - Aug 2016
    Baltimore, Md, Us
    I generated and characterized novel genetic rodent models to identify and validate biological targets of alpha-synuclein neurodegeneration. I identified and characterized c-Abl, a highly promising target for both therapeutic and biomarker development. Additionally, I identified a novel posttranslational modification of alpha-synuclein that contributes to Parkinson’s disease neurodegeneration. My study provided the first compelling evidence that c-Abl is a biological target of alpha-synuclein. I further contributed to the development of preclinical studies targeting c-Abl.• Discovery of c-Abl as a target led to the development of novel c-Abl kinase inhibitors with improved selectivity and conduction of multiple clinical trials.• Directly mentored and supervised research activity of undergraduate students.• Played significant role in collaborative research.• Wrote and published papers as senior author and co-author, wrote grants and progress reports.
  • Rush University Medical Center
    Post Doctoral Research Fellow
    Rush University Medical Center Jul 2009 - Aug 2010
    Chicago, Illinois, Us
  • Rush University Medical Center, Chicago, Il, Usa
    Graduate Research Assistant
    Rush University Medical Center, Chicago, Il, Usa Jul 2006 - May 2009
    Chicago, Illinois, Us
    I investigated immunoregulatory and neuroinflammatory mechanisms related neurodegenerative diseases with emphasis on Multiple sclerosis and Alzheimer’s diseases, and Parkinson’s disease. • Identified novel roles of iNOS-derived nitric oxide in immunomodulation.• Identified intermediates of cholesterol biosynthesis pathway as druggable targets contributing to neuroinflammation.• Preclinically evaluated repurposing of compounds for anti-inflammatory and neuroprotective efficacy using EAE (Experimental allergic encephalomyelitis), an animal model of multiple sclerosis. • Contributed to six first-authored publications, a first-authored review, a book chapter, as well as co-authored publications.• Gave both oral and poster presentations at scientific meetings/conferences.
  • University Of Nebraska
    Graduate Research Assistant
    University Of Nebraska Aug 2002 - Jun 2006
    Lincoln, Nebraska, Us
    I studied mechanisms of glial activation and immunomodulation relevant to neurodegenerative diseases.• Identified a novel role of iNOS-derived nitric oxide in astrogliosis.• Transferred to graduate program in Neuroscience, Department of Neurological Sciences, Rush University Medical Center, Chicago.
  • Govt Polytechnic College, Dept Of Pharmacy, Suri, Birbhum, Wb, India
    Lecturer In Pharmacy
    Govt Polytechnic College, Dept Of Pharmacy, Suri, Birbhum, Wb, India Apr 2001 - Jun 2002
  • College Of Pharmacy, Aligarh, Up, India
    Lecturer In Pharmacy
    College Of Pharmacy, Aligarh, Up, India Apr 2000 - Mar 2001
  • Solus Pharmaceuticals Ltd
    Marketing Executive
    Solus Pharmaceuticals Ltd Jul 1998 - Aug 1998

Saurav Brahmachari Skills

Western Blotting Neuroscience Cell Culture Cell Signaling Pcr Immunohistochemistry Molecular Biology Protein Expression Animal Models Hplc Neurodegeneration Rt Pcr Reverse Transcription Polymerase Chain Reaction Life Sciences Cell Biology Research Biochemistry High Performance Liquid Chromatography Polymerase Chain Reaction Confocal Microscopy Real Time Polymerase Chain Reaction Elisa Microscopy Fluorescence Microscopy In Vivo Stereology Stereotaxic Surgery Biomarker Discovery Manuscript Writing Grant Writing Generation And Characterization Of Animal Models High Throughput Sequencing Library Preparaion Neuodegeneration

Saurav Brahmachari Education Details

  • Rush University Medical Center, Chicago, Illinois, Usa
    Rush University Medical Center, Chicago, Illinois, Usa
    Neuroscience
  • University Of Nebraska, Ne, Usa
    University Of Nebraska, Ne, Usa
    Neuroscience
  • Jadavpur University
    Jadavpur University
    Biotechnology
  • Jadavpur University
    Jadavpur University
    Pharmacy

Frequently Asked Questions about Saurav Brahmachari

What company does Saurav Brahmachari work for?

Saurav Brahmachari works for Valtedseq

What is Saurav Brahmachari's role at the current company?

Saurav Brahmachari's current role is Senior Scientist at Valted Seq Inc. (A subsidiary of D&D Pharmatech).

What is Saurav Brahmachari's email address?

Saurav Brahmachari's email address is b.****@****ail.com

What schools did Saurav Brahmachari attend?

Saurav Brahmachari attended Rush University Medical Center, Chicago, Illinois, Usa, University Of Nebraska, Ne, Usa, Jadavpur University, Jadavpur University.

What are some of Saurav Brahmachari's interests?

Saurav Brahmachari has interest in Neurochemistry, Glia And Neuroinflammation, Neuroimmunology, Neuropharmacology.

What skills is Saurav Brahmachari known for?

Saurav Brahmachari has skills like Western Blotting, Neuroscience, Cell Culture, Cell Signaling, Pcr, Immunohistochemistry, Molecular Biology, Protein Expression, Animal Models, Hplc, Neurodegeneration, Rt Pcr.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.